Carta Healthcare, the leading provider of AI-powered clinical data abstraction solutions, has been named among CB Insights’ Digital Health 50, an honor reserved for the world’s highest-potential private companies in digital health.
CB Insights’ annual Digital Health 50 highlights private companies with strong growth potential, focusing on early-stage players with strong market traction, high-quality investors, and growing teams.
Carta Healthcare was honored in the Clinical Workflow Automation category and was selected as a member of the Digital Health 50 for its unprecedented advancements in clinical data abstraction through its Hybrid Intelligence approach, which combines state-of-the-art artificial intelligence with deep clinical expertise.
For health systems, Carta Healthcare has reduced clinical data abstraction costs by 50 percent or more, decreased clinical data abstraction time by up to two-thirds and delivered the highest-quality data as measured by Inter-rater Reliability (IRR) metrics. Carta Healthcare leads the industry, achieving an average 98-99 percent IRR across all its clients.
“This recognition reflects the measurable impact our solutions are having across the industry,” said Carta Healthcare CEO Brent Dover. “By combining cutting-edge AI with the expertise of our clinical professionals, we’re helping health systems spend less time on manual tasks and more time delivering exceptional patient care, and improving outcomes.”
Members of the CB Insights Digital Health 50 are chosen from an initial pool of more than 12,000 companies. Winners are selected based on CB Insights data, including deal activity, partnerships, leadership strength, hiring momentum, and investor quality.
